TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CRDF

Cardiff Oncology Inc

Healthcare · Biotechnology

1.40$ +5.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Cardiff Oncology Inc (CRDF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 62 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRDF
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
29 71 44 12 14 13 135 150 116 82 97 62
27 68 39 9.5 13 11 133 146 111 77 95 60
27 67 38 8.2 11 10 131 12 16 22 51 17
27 67 38 8.2 11 10 131 141 105 75 92 58
0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.5 0.8 0.3 0.8 0.2
-0.4 0.0 0.0 0.0
0.8 2.7 3.8 2.4 1.3 0.9 0.6 0.4 1.3
21 23 24 5.8 4.1 5.8 6.6 9.1 9.8 12 14 16
4.5 8.2 7.8 3.9 3.0 4.8 6.1 6.6 7.8 10 13 16
1.9 5.2 2.4 1.3 0.9 0.9 0.6 0.7 0.7 0.7 0.7
2.6 1.0 1.1 0.8 0.7 0.7 1.4 1.4 2.0 2.0 4.8 8.1
11 14
8.3 49 20 6.5 10 7.3 128 140 106 70 83 45
-81 -109 -148 -173 -192 -209 -231 -260 -298 -340 -384 -430
0.3 0.4 0.4 0.5 2.3 6.0 21 39 44 45 48 67

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?